Previous 10 | Next 10 |
Gainers: ZIVO Bioscience (NASDAQ:ZIVO) +71%. Aehr Test (NASDAQ:AEHR) +36%. Unique Fabricating (NYSE:UFAB) +32%. Meredith (NYSE:MDP) +26%. Paltalk (NASDAQ:PALT) +24%. Marin Software (NASDAQ:MRIN) +22%. ReWalk Robotics (NASDAQ:RWLK) +20%. Metacrine (NASDAQ:MTCR) +17%. Naked Brand Group (NASDAQ:...
Gainers: ZIVO Bioscience (NASDAQ:ZIVO) +68%, Pieris Pharmaceuticals (NASDAQ:PIRS) +11%, Molecular Templates (NASDAQ:MTEM) +11%, Paratek Pharmaceuticals (NASDAQ:PRTK) +9%, Capricor Therapeutics CAPR +4%. Losers: Kintara Therapeutics KTRA -19%, Oncon...
SAN DIEGO, Sept. 20, 2021 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE), a clinical stage biotherapeutics company engaged in the discovery and development of innovative medicines based on novel biological pathways, today announced the closing of an underwritten public offering of 10,...
LONDON, UK / ACCESSWIRE / September 20, 2021 / Love Hemp Group PLC (AQSE:LIFE)(OTCQB:WRHLF) , one of the UK's leading CBD and hemp product suppliers, announces that it has changed its registered office to Suite 1, 15 Ingestre Place, London, W1F 0DU from 14 September 2021. -ENDS- For furthe...
Listen on the go! A daily podcast of Wall Street Breakfast's Alpha Talks will be available this morning on Seeking Alpha, iTunes, Stitcher and Spotify. Stocks touched their lowest levels in four weeks Friday as inflation fears took hold and a range of Chinese economic indicators pointed to a ...
Palm Beach, FL – September 17, 2021 – FinancialNewsMedia.com News Commentary – The ovarian cancer drugs market consists of sales of ovarian cancer drugs to treat ovarian cancer. Ovarian cancer is caused due to abnormal growth of cells in ovary. This industry...
SAN DIEGO, Sept. 16, 2021 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel biological pathways, today announced that Sanjay S. Shukla, M.D., M.S., President and Chief Executive Off...
Gainers: Offerpad Solutions (NYSE:OPAD) +48%. Arqit Quantum (NASDAQ:ARQQ) +36%. AEye (NASDAQ:LIDR) +36%. Rockley (NYSE:RKLY) +29%. IronNet (NYSE:IRNT) +32%. Leap Therapeutics (NASDAQ:LPTX) +27%. aTyr Pharma (NASDAQ:LIFE) +27%. Tuesday Morning Corporation (NASDAQ:TUEM) ...
Shares of aTyr Pharma (NASDAQ:LIFE) are up 16% in morning trading after earlier this morning pricing a nearly 9.4M share underwritten public offering expected to net $75M. The company's lead candidate, ATYR1923, is in phase 2 for pulmonary sarcoidosis and COVID-19 related severe res...
SAN DIEGO, Sept. 16, 2021 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE), a clinical stage biotherapeutics company engaged in the discovery and development of innovative medicines based on novel biological pathways, today announced the pricing of an underwritten public offering of 9,3...
News, Short Squeeze, Breakout and More Instantly...
SAN DIEGO, June 03, 2024 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE) (“aTyr” or the “Company”), a clinical stage biotechnology company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform, today ann...
SAN DIEGO, May 15, 2024 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE) (aTyr or the “Company”), a clinical stage biotechnology company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform, today announced that the c...
Independent data and safety monitoring board (DSMB) recommends continuation of study without any modifications. Findings further support favorable safety profile of efzofitimod. SAN DIEGO, May 14, 2024 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE) (aTyr or the “Compa...